Harvey I. Pass

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib

Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases

p53: A Frequent Target for Genetic Abnormalities in Lung Cancer

Germline BAP1 mutations predispose to malignant mesothelioma

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

Neuroendocrine Tumors of the Lung With Proposed Criteria for Large-Cell Neuroendocrine Carcinoma

Photodynamic Therapy in Oncology: Mechanisms and Clinical Use

The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

BAP1 and cancer

Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis